Persistent Opioid Use High in Head, Neck Cancer Patients
FRIDAY, Jan. 11, 2019 -- Persistent opioid use at three and six months remains high among patients undergoing treatment for head and neck squamous cell cancer, according to a study recently published in Otolaryngology-Head and Neck Surgery.
Jessica...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Head and Neck Cancer | Pharmaceuticals | Squamous Cell Carcinoma | Study